Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-9920
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Safety and tolerability evaluation after repeated intravitreal injections of a humanized anti-VEGF-A monoclonal antibody (PRO-169) versus ranibizumab in New Zealand white rabbits ; volume:6 ; number:1 ; day:28 ; month:7 ; year:2020 ; pages:1-9 ; date:12.2020
International Journal of Retina and Vitreous ; 6, Heft 1 (28.7.2020), 1-9, 12.2020
- Creator
-
Baiza-Durán, Leopoldo
Sánchez-Ríos, Alejandra
González-Barón, Joel
Olvera-Montaño, Oscar
Correa-Gallegos, Elba
Navarro-Sánchez, Andrea
Muñoz-Villegas, Patricia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40942-020-00235-y
- URN
-
urn:nbn:de:101:1-2020092420275707261998
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Baiza-Durán, Leopoldo
- Sánchez-Ríos, Alejandra
- González-Barón, Joel
- Olvera-Montaño, Oscar
- Correa-Gallegos, Elba
- Navarro-Sánchez, Andrea
- Muñoz-Villegas, Patricia
- SpringerLink (Online service)
Other Objects (12)
Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Iatrogenic Retinal Penetration from Intravitreal Injections
How to prevent endophthalmitis after intravitreal injections
Occlusive retinal vasculitis associated with intravitreal Faricimab injections
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study
Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Iatrogenic Retinal Penetration from Intravitreal Injections
How to prevent endophthalmitis after intravitreal injections
Occlusive retinal vasculitis associated with intravitreal Faricimab injections
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study
Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Iatrogenic Retinal Penetration from Intravitreal Injections
How to prevent endophthalmitis after intravitreal injections
Occlusive retinal vasculitis associated with intravitreal Faricimab injections
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study